As the world is scrambling to develop a COVID-19 vaccine, Principal Investigator of vaccine trial team at Rohtak PGI Doctor Savita Verma informed that part 1 of phase-1 of Covaxin trial is completed and it shows encouraging results.
"Part 1 of phase-1 of vaccine trial (Covaxin) completed.
50 people across India were administered the vaccine, results encouraging.
6 people were administered vaccine today under part 2 of phase-1," said Verma.
